Innovative Funding Models for Non-Communicable Diseases

By Staff Writer

July 5, 2024

Introduction

Non-communicable diseases (NCDs) pose a significant health burden globally, especially in low- and middle-income countries (LMICs). These diseases account for 77% of related deaths worldwide, with cardiovascular diseases, cancer, and chronic respiratory diseases being the most prevalent. The disparity in healthcare access between developed and developing nations exacerbates this issue. Economically advanced countries invest more in healthcare due to their financial capacity, unlike LMICs where investment is suboptimal. The Professional Society for Health Economics and Outcomes Research (ISPOR) Arabic Network explored innovative funding models for NCDs in LMICs, focusing on strategies from Morocco, Lebanon, and Egypt.

The Disproportionate Burden of NCDs in LMICs

Dr Rita Karam, Chair of the ISPOR Arabic Network, highlighted the urgent need for innovative funding models at the ISPOR Europe 2023 forum. She pointed out that economically developed nations spend more on healthcare due to their financial capacity. In contrast, LMICs struggle with suboptimal investment and access to healthcare. Dr Karam emphasised the importance of adequate funding and financing for healthcare, which is crucial for achieving Universal Health Coverage (UHC).

Dr Karam introduced several innovative funding models, such as Development Impact Bonds and new tax-based ideas. These models aim to address the unique needs of each country and fill the funding gap for NCDs. Emphasising prevention, early intervention, and improved patient outcomes, she underscored the critical need for these innovative funding solutions.

Morocco: Financing Challenges in Health Innovation

In Morocco, healthcare expenses are growing faster than financial resources. Dr Amal Yassine from the Moroccan Society for Health Products Economics (SMEPS) discussed the challenges Morocco faces. The generalisation of compulsory health insurance has led to a continuous increase in health expenditure. This poses a challenge in strengthening access to quality care and medical services under economic constraints.

Morocco’s elderly population, aged over 60 years, constitutes 12.2% of the demographic, with a life expectancy of 76.7 years. NCD mortality is the leading cause of death in the country. Households bear 46% of the health expenditure burden. The system’s current objective is to optimise available resources to ensure long-term viability. This includes strengthening regulatory tools and integrating therapeutic innovation through health technology assessments (HTAs).

Lebanon: Navigating Healthcare Challenges Amid an Economic Crisis

Lebanon is facing an unparalleled economic crisis, significantly impacting all sectors, including healthcare. Dr Wadih Mina highlighted the country’s efforts to address this crisis through various measures. Lebanon’s currency has depreciated by over 90%, severely limiting the ability to afford healthcare costs, especially for imported consumables priced in foreign currency.

Lebanon’s response includes short-term strategies like the widespread subsidy of imported medicines. Longer-term initiatives involve establishing a universal health coverage law. These measures aim to provide valuable insights for other nations facing similar challenges. Dr Mina invited further research to document Lebanon’s experience and provide insights for other countries.

Egypt: Opportunities for Innovative Health Financing

Healthcare funding in Egypt is fragmented, with multiple sources of funding. Dr Mahmoud Elmahdawy discussed Egypt’s ongoing changes to achieve UHC. The largest healthcare expenditures, approximately 55%, are attributed to NCDs, presenting a significant burden. A high percentage of mortality in Egypt is linked to NCDs.

This underscores the need for a heightened focus on prevention, awareness, and public health campaigns. Further utilisation of HTA principles is essential to optimise healthcare spending. Outcomes-based agreements are currently being explored to encourage systematic evidence-based decisions for healthcare priority setting.

Conclusion

The disproportionate burden of NCDs in LMICs necessitates innovative funding models to address healthcare challenges. Morocco, Lebanon, and Egypt provide valuable insights into the strategies and success stories of implementing these models. Emphasising prevention, early intervention, and improved patient outcomes is crucial for strategies on mitigating the growing burden of NCDs. By adopting innovative funding solutions, LMICs can work towards achieving Universal Health Coverage and improving healthcare access for their populations.

Reference url

Recent Posts

EU Life Sciences Strategy
         

EU Life Sciences Strategy: Paving the Way for Europe’s Leadership by 2030

🚀 Is Europe poised to reclaim its leadership in life sciences by 2030?

The European Commission has unveiled a game-changing strategy aimed at transforming the EU into the world’s leading hub for life sciences, tackling critical challenges in health, biotechnology, and sustainability. With strategic investments and reforms, this initiative promises to bridge the innovation gap and enhance public health outcomes across the continent.

Curious about how these plans will impact the life sciences landscape? Explore the full insights of this exciting strategy!

#SyenzaNews #HealthcareInnovation #DigitalTransformation #Innovation

ticagrelor data integrity
          

Ticagrelor Data Integrity Under Fire: Scrutiny Reveals Flaws in Key Clinical Trials

🔍 Are we truly getting the full story on high-cost medications like ticagrelor?

A recent BMJ investigation has raised alarm bells over the integrity of data from pivotal studies on AstraZeneca’s ticagrelor, revealing significant misreporting and missing data that may undermine its clinical benefits. This exposes critical implications for health economics, regulatory oversight, and market access.

Curious about how these findings could reshape perceptions of drug efficacy and safety? Dive into the full article to uncover the truth behind the numbers.

#SyenzaNews #HealthEconomics #Pharmaceuticals #MarketAccess

self-care public health
    

The Value of Self-Care in Public Health: Insights and Implications for Europe

🌍 Are we overlooking the power of self-care in Europe’s public health strategy?

The rise of self-care public health is reshaping how minor ailments are managed across the continent, leading to remarkable economic and productivity benefits. With annual savings of €36 billion and lifestyle improvements for consumers, self-care is proving to be a game-changer for healthcare systems.

Explore how embracing self-care can alleviate pressure on healthcare providers and enhance individual well-being. Dive into the full article to discover the implications for health economics and public policy!

#SyenzaNews #HealthEconomics #HealthcarePolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.